Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 451, 21-22 (3 January 2008) | doi:10.1038/451021a; Published online 2 January 2008
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Full-Professor of Heart and Thoracic Surgery (W3) (f / m)
- Friedrich-Schiller-University Jena
- Jena Germany
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Down's syndrome: Paradox of a tumour repressor
David W. Threadgill1
Abstract
Having three copies of chromosome 21 reduces the incidence of solid tumours in people with Down's syndrome. Studies in mice provide clues to why, and highlight a complex gene–function relationship.
Correlative epidemiological studies are powerful analytical tools that can provide insight into human health and disease. A case in point is the proposition1 that the age-adjusted incidence of solid tumours is lower in individuals with Down's syndrome than in the general population.
- David W. Threadgill is in the Department of Genetics, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Email: dwt@med.unc.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Protects Against Focal Brain Ischemia in Hypertensive RatsJournal of Cerebral Blood Flow & Metabolism Original Article
Trisomy represses Apc Min -mediated tumours in mouse models of Down?s syndromeNature Letters to Editor (03 Jan 2008)
